146 related articles for article (PubMed ID: 37128849)
1. Understanding Long-Term Survival of Patients with Ovarian Cancer-The Tumor Microenvironment Comes to the Forefront.
Kelliher L; Lengyel E
Cancer Res; 2023 May; 83(9):1383-1385. PubMed ID: 37128849
[TBL] [Abstract][Full Text] [Related]
2. Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors.
Ferri-Borgogno S; Zhu Y; Sheng J; Burks JK; Gomez JA; Wong KK; Wong STC; Mok SC
Cancer Res; 2023 May; 83(9):1503-1516. PubMed ID: 36787106
[TBL] [Abstract][Full Text] [Related]
3. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
Front Immunol; 2021; 12():643529. PubMed ID: 33679807
[No Abstract] [Full Text] [Related]
4. Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian Cancer.
Loret N; Vandamme N; De Coninck J; Taminau J; De Clercq K; Blancke G; Jonckheere S; Goossens S; Lemeire K; De Prijck S; Verstaen K; Seurinck R; Van Dorpe J; Weyers S; Denys H; Van de Vijver K; Lambrecht BN; Tummers P; Saeys Y; Berx G
Mol Cancer Res; 2022 Oct; 20(10):1532-1547. PubMed ID: 35749080
[TBL] [Abstract][Full Text] [Related]
5. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
[TBL] [Abstract][Full Text] [Related]
6. Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer.
Carvalho RF; do Canto LM; Abildgaard C; Aagaard MM; Tronhjem MS; Waldstrøm M; Jensen LH; Steffensen KD; Rogatto SR
Cell Commun Signal; 2022 Nov; 20(1):176. PubMed ID: 36352420
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma.
Li Y; Tian R; Liu J; Li J; Tan H; Wu Q; Fu X
Front Immunol; 2022; 13():940801. PubMed ID: 36119108
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.
Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.
Guan J; Darb-Esfahani S; Richter R; Taube ET; Ruscito I; Mahner S; Woelber L; Prieske K; Concin N; Vergote I; Van Nieuwenhuysen E; Achimas-Cadariu P; Glajzer J; Woopen H; Stanske M; Kulbe H; Denkert C; Sehouli J; Braicu EI
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1063-1073. PubMed ID: 30810838
[TBL] [Abstract][Full Text] [Related]
10. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma.
Deng Y; Tan Y; Zhou D; Bai Y; Cao T; Zhong C; Huang W; Ou Y; Guo L; Liu Q; Yin D; Chen L; Luo X; Sun D; Sheng X
Front Immunol; 2022; 13():923194. PubMed ID: 35935940
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
14. Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors.
Yang SYC; Lheureux S; Karakasis K; Burnier JV; Bruce JP; Clouthier DL; Danesh A; Quevedo R; Dowar M; Hanna Y; Li T; Lu L; Xu W; Clarke BA; Ohashi PS; Shaw PA; Pugh TJ; Oza AM
Genome Med; 2018 Oct; 10(1):81. PubMed ID: 30382883
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
17. Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer.
Colvin EK; Howell VM; Mok SC; Samimi G; Vafaee F
Cancer Sci; 2020 May; 111(5):1805-1817. PubMed ID: 32058624
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread.
Gendrau-Sanclemente N; Figueras A; Gracova K; Lahiguera Á; Alsina-Sanchís E; Marín-Jiménez JA; Vidal A; Matias-Guiu X; Fernandez-Gonzalez S; Barahona M; Martí L; Ponce J; Viñals F
Mol Oncol; 2024 Jan; 18(1):136-155. PubMed ID: 38010623
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
[No Abstract] [Full Text] [Related]
20. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
Yue H; Li W; Chen R; Wang J; Lu X; Li J
Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
